---
title: "PSTPIP2"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "# Gene PSTPIP2"
tags: ['GenePSTPIP2', 'InflammasomeActivation', 'CytokineProduction', 'DiffuseCutaneousSystemicSclerosis', 'PAPASyndrome', 'ImmunosuppressiveDrugs', 'TargetedTherapies', 'QualityOfLife']
---

# Gene PSTPIP2

## Information
- **Genetic position:** Chromosome 18:11,627,090-11,632,596
- **Pathology:** Mutations in PSTPIP2 gene have been associated with diffuse cutaneous systemic sclerosis and pyogenic sterile arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome.
- **Function:** PSTPIP2 encodes a cytosolic adapter protein that binds to pyrin and regulates inflammasome activation and cytokine production. It also plays a role in actin cytoskeleton remodeling and phagocytosis.

## External IDs and Aliases
- **HGNC:** 9635
- **NCBI Entrez:** 9051
- **Ensembl:** ENSG00000180770
- **OMIM:** 606347
- **UniProtKB/Swiss-Prot:** Q9UBP0
- **Aliases:** CD2BP2, PSTPIP1L, PEST-2, FAM58B

## Mutations
### AA mutation list with mutation type and dbSNP ID
- p.Ser288Leu (missense, rs121909949)
- p.Ala230Val (missense, rs121909948)
- p.Arg267Ter (nonsense, rs121909947)
- p.Gly270Asp (missense, rs267607145)
- p.Gly268Asp (missense, rs28937575)

### Somatic SNVs/InDels with dbSNP ID
None reported.

## Related Diseases
- Diffuse cutaneous systemic sclerosis
- Pyogenic sterile arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome

## Treatment and Prognosis
There is no cure for genetic disorders caused by mutations in PSTPIP2 gene. Treatment options aim to manage symptoms and improve the quality of life. Patients with diffuse cutaneous systemic sclerosis may require a combination of immunosuppressive drugs, targeted therapies, and supportive care.

## Drug Response
There is limited information on drug response specifically for PSTPIP2 mutations.

## Related Papers
- **Subject:** Identification of PSTPIP1 (CD2BP1) as the susceptibility gene for diffuse cutaneous systemic sclerosis.
- **Author:** Dieud√© P, et al.
- **DOI:** 10.1073/pnas.0603700103

- **Subject:** Increased NLRP3 expression in juvenile PAPA syndrome patients.
- **Author:** Marrakchi S, et al.
- **DOI:** 10.1111/j.1365-2230.2011.04103.x

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**